OAKLANDS — All Prescriptions & Medications — Page 13
Practice Code: N81039 | MIDDLEWICH, CW10 9BE
Showing results 601-632 of 632
| Medication | Items (12m) ↓ | Quantity | Cost | vs National |
|---|---|---|---|---|
| 13 | 274 | £156 | -83.8% ▼ | |
| Promazine hydrochloride | 12 | 672 | £383 | -77.3% ▼ |
| Tetrabenazine | 12 | 658 | £719 | -24.3% ▼ |
| Metronidazole | 12 | 520 | £53 | +81.5% ▲ |
| Solifenacin/tamsulosin | 12 | 354 | £310 | -41.6% ▼ |
| Etodolac | 12 | 360 | £177 | -56.7% ▼ |
| Ketoprofen | 12 | 1,400 | £61 | -66.6% ▼ |
| Mometasone furoate/olopatadine hydrochloride | 12 | 12 | £152 | +10.5% ▲ |
| Zinc oxide | 12 | 1,355 | £53 | -40.3% ▼ |
| Salicylic acid | 12 | 136 | £48 | -5.1% ▼ |
| 12 | 1,405 | £1.9K | +44.6% ▲ | |
| 12 | 145 | £740 | +76.9% ▲ | |
| Doxylamine succinate/pyridoxine hydrochloride | 11 | 380 | £542 | -0.3% vs avg |
| Opicapone | 11 | 328 | £645 | -42.5% ▼ |
| Erythromycin ethylsuccinate | 11 | 3,000 | £285 | -52.9% ▼ |
| Ofloxacin | 11 | 239 | £288 | +33.9% ▲ |
| Cinacalcet hydrochloride | 11 | 220 | £52 | -52.6% ▼ |
| Tube feed 1.2 kcal/ml with fibre, higher protein (0914011) | 11 | 411.0K | £7.3K | +0.9% vs avg |
| Piroxicam | 11 | 1,288 | £34 | -80.9% ▼ |
| Hydrocort sodiumphos | 11 | 630 | £219 | +43.7% ▲ |
| Tafluprost | 11 | 480 | £195 | -40.7% ▼ |
| 11 | 2,200 | £119 | -56.3% ▼ | |
| 11 | 20 | £53 | +26.0% ▲ | |
| 11 | 55 | £121 | +69.2% ▲ | |
| Fluvoxamine maleate | 10 | 674 | £222 | -17.7% ▼ |
| Oestrogens conjugated | 10 | 1,288 | £472 | -51.0% ▼ |
| Goserelin acetate | 10 | 10 | £1.2K | -77.3% ▼ |
| Ferrous gluconate | 10 | 476 | £14 | -79.1% ▼ |
| Powder 1.5 kcal/ml smoothie plant based (0913011) | 10 | 616 | £623 | -7.3% ▼ |
| Capsaicin | 10 | 582 | £326 | +26.7% ▲ |
| Budesonide | 10 | 16 | £157 | -35.7% ▼ |
| 10 | 13 | £217 | +47.0% ▲ |
Data sourced from NHSBSA English Prescribing Dataset, CQC, and GP Patient Survey. Prescribing data does not indicate quality of care. Higher prescribing rates may reflect patient demographics. Always consult your GP for medical advice.